Clinical Characteristics and Risk Factors of Immune Checkpoint Inhibitor‐Related Myocarditis: A Real World Observational Study

Key Points

• This study aims to identify the clinical characteristics and risk factors associated with myocarditis caused by immune checkpoint inhibitors.
• Conducted a real-world observational study of individuals undergoing treatment with immune checkpoint inhibitors.
• Collected data on clinical characteristics and potential risk factors for myocarditis.
• Identified several key clinical characteristics associated with immune checkpoint inhibitor-related myocarditis.
• Found specific risk factors that increased the likelihood of developing myocarditis.